MAPK3 and posterior cortical atrophy: Collectively, these findings imply that AZGP1P2 promotes the chemotherapy of docetaxel by inhibiting PCa cell growth and migration as well as the metastasis of PCa through the AZGP1P2/UBA1/RBM15-TPM1-ERK1/2 cascade.